Intuitive Surgical (NASDAQ:ISRG) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Tuesday, April 16th, BidAskClub reports.
Other equities research analysts have also issued research reports about the stock. Deutsche Bank started coverage on shares of Intuitive Surgical in a report on Monday, April 1st. They issued a “buy” rating and a $630.00 price target for the company. Cantor Fitzgerald restated a “buy” rating and issued a $620.00 price target on shares of Intuitive Surgical in a report on Friday, January 25th. Stifel Nicolaus reduced their price target on shares of Intuitive Surgical from $600.00 to $570.00 and set a “buy” rating for the company in a report on Friday, January 25th. Citigroup cut their price objective on shares of Intuitive Surgical from $601.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, January 2nd. Finally, Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $540.00 price objective on the stock in a research report on Wednesday, December 19th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $578.94.
Shares of ISRG stock traded up $0.36 during trading hours on Tuesday, reaching $496.06. 621,183 shares of the stock were exchanged, compared to its average volume of 787,529. Intuitive Surgical has a 12-month low of $430.24 and a 12-month high of $589.32. The stock has a market cap of $56.72 billion, a PE ratio of 52.27, a P/E/G ratio of 4.43 and a beta of 1.02.
In other news, CEO Gary S. Guthart sold 22,636 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $501.48, for a total value of $11,351,501.28. Following the sale, the chief executive officer now directly owns 386,866 shares of the company’s stock, valued at approximately $194,005,561.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Curet Myriam sold 1,410 shares of the business’s stock in a transaction on Wednesday, February 20th. The shares were sold at an average price of $546.56, for a total transaction of $770,649.60. Following the completion of the transaction, the executive vice president now owns 2,417 shares of the company’s stock, valued at $1,321,035.52. The disclosure for this sale can be found here. Insiders sold a total of 32,266 shares of company stock worth $16,451,271 over the last ninety days. Insiders own 1.70% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of ISRG. Icon Wealth Partners LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $26,000. Bremer Bank National Association acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $164,000. Citizens Financial Group Inc RI raised its position in shares of Intuitive Surgical by 383.3% in the first quarter. Citizens Financial Group Inc RI now owns 87 shares of the medical equipment provider’s stock valued at $49,000 after buying an additional 69 shares during the last quarter. BlackRock Inc. raised its position in shares of Intuitive Surgical by 1.2% in the first quarter. BlackRock Inc. now owns 8,424,675 shares of the medical equipment provider’s stock valued at $4,806,951,000 after buying an additional 96,860 shares during the last quarter. Finally, Signaturefd LLC raised its position in shares of Intuitive Surgical by 17.6% in the first quarter. Signaturefd LLC now owns 641 shares of the medical equipment provider’s stock valued at $366,000 after buying an additional 96 shares during the last quarter. Hedge funds and other institutional investors own 84.93% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Article: Calculate Your Return on Investment (ROI)
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.